Your session is about to expire
← Back to Search
Subcutaneous Catheter for Female Infertility
This trial is testing whether a subcutaneous catheter is a feasible option for controlled ovarian stimulation in IVF, as it would be less physically and emotionally burdensome for patients and their partners than daily or twice daily injections.
- Female Infertility
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- There are no specific requirements or restrictions to participate in the clinical trial.
- Group 1: IVF with Neria™ Guard device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is age a factor for qualification in this clinical examination?
"The age range of participation in this medical trial is 18-45 years old. However, there are 14 research initiatives targeting those below the legal adult age and 33 studies focusing on individuals over 65."
Are there any vacancies remaining in this medical experiment?
"Clinicaltrials.gov reveals that this healthcare study, which was published on December 1st 2022 and revised recently on August 16th of the same year, is not currently accepting patients. However there are 246 other trials actively enrolling volunteers at the moment."
Is there any opportunity to join the research protocol?
"A total of 10 women aged 18 to 45 that have fertility difficulties need to be enrolled in this trial. In addition, all applicants must currently go through controlled ovarian stimulation as part of their treatment."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends